Samlyn Capital, LLC Viatris Inc Transaction History

Samlyn Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $25.3 Million - $39.7 Million	-2,576,849 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $31.2 Million - $37.8 Million	2,576,849 New	2,576,849 $34.9 Million
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $31.7 Million - $39.5 Million	-2,445,584 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $93.6 Million - $128 Million	-6,890,768 Reduced 73.81%	2,445,584 $34.2 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $134 Million - $175 Million	9,336,352 New	9,336,352 $175 Million

1,100

969M

2.63M

2.15M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.